Skip to content

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.

A Randomized Double-Blind Placebo-Controlled Pilot Study of L-tyrosine and L-tryptophan in Depressed Patients Receiving L-methylfolate and and SSRI

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02223299
Enrollment
0
Registered
2014-08-22
Start date
2015-11-30
Completion date
2015-11-30
Last updated
2020-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, SSRI, Nutritional Supplements, Beck Depression Scale

Brief summary

\*\*This study never received IRB approval and no participants were ever enrolled\*\* The purpose of this study is to determine if adding over the counter nutritional supplements will have a benefit to participants currently taking prescribed antidepressants who have not experienced complete remission of their depression symptoms.

Detailed description

Inclusion Criteria: Detroit VA Patients with major depression, mild to moderate treated with an SSRI and not having complete remission of symptoms as defined by feeling their normal selves Randomized into two groups: Experimental: will receive month supply of deplin 15mg, L-tyrosine 6g/d into 2 divided doses, and L-tryptophan 2g/d into 2 divided doses. Control: will receive month supply of deplin 15mg , and 2 placebo pills. Beck Depression Scale (BDI-2) to be administered at baseline and every 2 weeks for 1 month.

Interventions

DIETARY_SUPPLEMENTL-tyrosine

6g/d daily for 30 days

DIETARY_SUPPLEMENTL-Tryptophan

2g/d daily for 30 days

DRUGdeplin

15mg daily for 30 days

a sugar-pill that looks like a real medication

a sugar-pill that looks like a real medication

Sponsors

John D. Dingell VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\*\*This study never received IRB approval and no participants were enrolled\*\* Inclusion Criteria: * Veterans Administration Medical Center patients with major depression, mild to moderate treated with an SSRI and not having complete remission of symptoms.

Design outcomes

Primary

MeasureTime frameDescription
Benefit of nutritional supplement30 daysThrough participant interviews and Beck Depression scale determine if adding nutritional supplements improve or resolve complete remission of depression symptoms.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026